Peptides have become one of the most talked-about areas of modern medicine, driven in part by the remarkable visibility of medications such as GLP-1 therapies.
But peptide pharmaceuticals aren't new.
For decades, human medicine has used peptide-based drugs to influence highly specific biological processes, from controlling blood glucose to regulating hormones and treating osteoporosis.
As veterinary medicine explores increasingly individualized approaches to care, the experience of human healthcare raises an interesting question:
What could the evolution of peptide pharmaceuticals teach us about future opportunities in animal health?
What Are Peptide Therapies?
Peptides are short chains of amino acids that often function as signaling molecules within the body.
Think of them as biological instructions. Depending on the peptide, that instruction might tell the body to release insulin, regulate a hormone, influence appetite, alter metabolism, or activate another physiological response.
That ability to interact with specific biological pathways is one reason peptides have become valuable pharmaceutical tools.
And many people are already more familiar with peptide medications than they realize.
Peptides Are Already Part of Everyday Human Medicine
Some of today's most recognizable pharmaceuticals are peptide-based or peptide-derived therapies.
Insulin
Perhaps the most familiar example, insulin has transformed diabetes from what was once a frequently fatal disease into a manageable chronic condition for millions of people.
Semaglutide
A GLP-1 receptor agonist used in human medicine for type 2 diabetes and, in certain formulations, chronic weight management and cardiovascular risk reduction.
Tirzepatide
A dual GIP and GLP-1 receptor agonist used for type 2 diabetes and chronic weight management.
Liraglutide
Another GLP-1 receptor agonist that has established applications in diabetes and weight management.
Glucagon
A naturally occurring peptide hormone that can be administered as a medication to treat severe hypoglycemia.
Teriparatide
A parathyroid hormone analog used in certain patients with osteoporosis to stimulate new bone formation.
Calcitonin
A peptide hormone that has been used therapeutically in certain disorders involving bone metabolism.
These examples illustrate something important.
Peptides aren't a single category of treatment designed to accomplish one thing. Different peptides can influence entirely different biological systems.
That's what makes the field so interesting.
The Future of Peptide Therapies in Veterinary Medicine
Veterinary medicine already has experience with peptide pharmaceuticals.
Insulin is routinely used in dogs and cats with diabetes, demonstrating that peptide-based treatment already has an important place in animal health.
The larger question is where peptide science could go next.
Researchers are studying peptide-related approaches across numerous areas of medicine, creating potential avenues for future veterinary investigation.
Metabolic and Endocrine Health
The success of peptide hormones and receptor-targeted therapies in human medicine demonstrates how precisely certain metabolic pathways can be influenced.
For veterinary researchers, similar biological mechanisms may create opportunities to better understand metabolic and endocrine diseases affecting different animal species.
Tissue Repair and Regeneration
Some peptides participate naturally in signaling pathways associated with tissue growth, blood vessels, inflammation, and repair.
Understanding those pathways could eventually contribute to research involving wound healing, orthopedic recovery, or regenerative medicine.
Importantly, many peptides promoted commercially for "healing" or "recovery" remain investigational and should not be confused with therapies that have established veterinary safety and efficacy.
Immune and Inflammatory Disease
Peptides also participate in immune communication.
As scientists better understand these signaling mechanisms, peptide research could potentially contribute to more targeted approaches to inflammatory or immune-mediated conditions.
Antimicrobial Research
Another particularly interesting area involves antimicrobial peptides, molecules that form part of the natural immune defenses of many organisms.
Scientists are investigating whether certain antimicrobial peptides could eventually provide new approaches for combating infectious organisms, an important area of research as medicine continues confronting antimicrobial resistance.
Oncology
Cancer treatment is increasingly moving toward therapies that recognize specific molecular characteristics of tumors.
Peptides are being studied in human medicine for roles ranging from targeting particular receptors to delivering therapeutic or diagnostic agents more selectively.
That same scientific concept, identifying a biological target and designing treatment around it, could eventually have implications for veterinary oncology.
The Human Healthcare Lesson Isn't "Use More Peptides"
Perhaps the most important lesson from human medicine isn't any particular drug.
It's the process.
Successful peptide pharmaceuticals didn't become standards of care simply because their biological mechanisms were interesting.
They required research.
Researchers had to determine what the molecule did, which patients might benefit, how it should be administered, what dose was appropriate, what adverse effects could occur, and whether the benefits outweighed the risks.
Veterinary medicine requires the same standard.
Dogs aren't small humans. Cats aren't small dogs. Horses, companion animals, and other species can metabolize and respond to medications very differently.
A peptide showing promise in human medicine therefore doesn't automatically translate into an appropriate veterinary therapy.
From Personalized Medicine to Precision Medicine
This is where the peptide conversation becomes especially interesting.
The future may not simply involve having more medications available.
It may involve becoming increasingly precise about which biological pathway we're trying to influence, in which patient, for which condition.
That represents a meaningful evolution in individualized veterinary care.
Instead of asking only:
"What medication treats this disease?"
Medicine may increasingly be able to ask:
"What biological mechanism is driving this patient's disease, and can we target it more precisely?"
Peptide science is one of several fields helping researchers explore that question.
How ePrescribing Can Support More Complex Veterinary Therapies
As veterinary medicine becomes more precise, the prescribing process may become more complex as well.
More individualized treatment can mean navigating specialized medications, different strengths and dosage forms, compounded formulations, and increasingly complex formularies.
That creates a challenge beyond developing the therapy itself.
Veterinarians also need technology capable of supporting the growing number of variables that can accompany a prescription without making the prescribing process more difficult.
This is where veterinary ePrescribing can play an important role.
Instead of requiring veterinarians to navigate disconnected formularies, pharmacy workflows, and manual prescribing processes, modern ePrescribing technology can bring those variables into a more streamlined digital experience.
The goal isn't to eliminate the complexity behind modern veterinary medicine. In many cases, that complexity exists because treatment is becoming more specialized and more tailored to the individual patient.
The goal is to make that complexity easier for veterinarians to manage.
Where VetWay Fits
That's part of what we're building with VetWay.
As veterinary formularies continue to expand, prescribing technology needs the flexibility to support standard medications alongside more complex prescribing scenarios involving different strengths, dosage forms, compounded medications, specialty pharmaceuticals, and other patient-specific requirements.
VetWay ePrescribing is being designed to make complex formulary prescribing feel simple.
By bringing medication selection, prescribing variables, and pharmacy connectivity into a more streamlined digital workflow, veterinarians can navigate the options appropriate for their patient and electronically transmit the prescription to the appropriate pharmacy.
As treatment options become more sophisticated, the technology supporting veterinarians should become easier to use, not harder.
More complex medicine shouldn't require more complicated prescribing.
Proceeding With Curiosity and Evidence
Peptides offer a fascinating window into where pharmaceutical science could be heading.
Human healthcare has already demonstrated that peptide drugs can become transformative treatments when the biology, clinical evidence, manufacturing standards, dosing, and regulatory oversight align.
Veterinary medicine may uncover additional opportunities of its own.
Innovation should be balanced with careful, evidence-based evaluation.
Some peptide medications are well established. Others are being actively researched. Still others are promoted commercially despite limited evidence regarding their safety or effectiveness in veterinary patients.
Those distinctions matter.
The most exciting future isn't one in which veterinary medicine simply adopts whatever becomes popular in human healthcare.
It's one in which veterinary researchers and clinicians take what human medicine has learned, investigate the biology within individual animal species, and determine where peptide science can genuinely improve outcomes.
Peptides may ultimately prove valuable not because they're new or trending, but because certain peptides may allow medicine to become more precise.
And as veterinary medicine becomes more precise, the technology supporting veterinarians will need to evolve alongside it.
Frequently Asked Questions (FAQ)
Are peptide therapies already used in veterinary medicine?
Yes. One of the most established examples is insulin, a peptide medication commonly used to treat diabetes in dogs and cats. Researchers are also exploring additional peptide-based therapies for a variety of potential veterinary applications.
What conditions could peptide therapies help treat in animals?
Researchers are studying peptides for potential applications in metabolic and endocrine disorders, tissue repair, wound healing, immune-mediated conditions, infectious diseases, and certain types of cancer. Many of these potential veterinary applications remain investigational.
Are GLP-1 medications used in pets?
GLP-1 receptor agonists have transformed areas of human medicine, but their potential applications in veterinary patients remain an area of ongoing research. Human medications should not be assumed to be safe or effective in animals without appropriate veterinary evidence and guidance.
Why is species-specific research important for peptide therapies?
Dogs, cats, horses, and other animals can metabolize and respond to medications differently than humans. A peptide that is effective in people may not be safe or effective in veterinary patients without appropriate species-specific research and clinical evaluation.
What is precision medicine, and how does it relate to peptide therapies?
Precision medicine focuses on tailoring treatment based on the biological characteristics driving disease in an individual patient. Because peptides can interact with specific receptors and signaling pathways, peptide science may contribute to increasingly targeted approaches to veterinary care.
How could ePrescribing support more complex veterinary therapies?
As veterinary treatment options expand, veterinarians may need to navigate more complex formularies, specialized medications, compounded formulations, and patient specific prescribing requirements. Veterinary ePrescribing can help organize those variables into a more streamlined digital workflow and electronically connect prescriptions with the appropriate pharmacy.